<DOC>
	<DOC>NCT01553006</DOC>
	<brief_summary>Cefditoren pivoxil has been used in rhinosinusitis treatment. However, little is known about the efficacy of this drug at low and high doses.</brief_summary>
	<brief_title>Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis</brief_title>
	<detailed_description>The investigation was a randomized, investigator-blinded, and parallel study, conducted in patients (age 1-15 years) with acute rhinosinusitis. Two groups of patients were randomized received low (10 MKD) or high (20 MKD) of drug for 14 days. Changes in sinus symptoms scores, response rate and adverse effect were evaluated at days 7 and 14. Relapse rate was recorded at days 21 and 28. Recurrence of sinus symptoms at day 60 were assessed.</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Cefditoren</mesh_term>
	<mesh_term>Cefditoren pivoxil</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>children age 115 years old diagnosed acute rhinosinusitis poor compliance other infections</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>rhinosinusitis</keyword>
	<keyword>cefditoren pivoxil</keyword>
</DOC>